Fluorine in PDB 7wmu: Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146
Protein crystallography data
The structure of Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146, PDB code: 7wmu
was solved by
J.Li,
C.Zhang,
H.Xu,
X.Zhuang,
X.Wu,
Y.Zhang,
Y.Xu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
42.45 /
1.73
|
Space group
|
I 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
48.41,
35.57,
73.563,
90,
96.51,
90
|
R / Rfree (%)
|
15 /
18.5
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146
(pdb code 7wmu). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146, PDB code: 7wmu:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 7wmu
Go back to
Fluorine Binding Sites List in 7wmu
Fluorine binding site 1 out
of 4 in the Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:20.3
occ:0.50
|
FBO
|
A:JGF501
|
0.0
|
20.3
|
0.5
|
CBM
|
A:JGF501
|
1.4
|
10.4
|
0.5
|
CBI
|
A:JGF501
|
1.4
|
17.2
|
0.5
|
CBL
|
A:JGF501
|
2.2
|
10.5
|
0.5
|
CBJ
|
A:JGF501
|
2.5
|
16.9
|
0.5
|
CAV
|
A:JGF501
|
2.5
|
15.5
|
0.5
|
CAV
|
A:JGF501
|
2.5
|
9.8
|
0.5
|
OAU
|
A:JGF501
|
2.8
|
13.7
|
0.5
|
CAT
|
A:JGF501
|
3.0
|
12.2
|
0.5
|
OAU
|
A:JGF501
|
3.0
|
9.5
|
0.5
|
CAS
|
A:JGF501
|
3.1
|
12.0
|
0.5
|
CAT
|
A:JGF501
|
3.1
|
9.7
|
0.5
|
OAG
|
A:JGF501
|
3.2
|
11.6
|
0.5
|
OAG
|
A:JGF501
|
3.2
|
10.4
|
0.5
|
CAL
|
A:JGF501
|
3.2
|
13.6
|
0.5
|
CAL
|
A:JGF501
|
3.2
|
14.4
|
0.5
|
CAS
|
A:JGF501
|
3.2
|
9.9
|
0.5
|
CD2
|
A:LEU381
|
3.4
|
20.5
|
1.0
|
CBK
|
A:JGF501
|
3.5
|
10.9
|
0.5
|
CBI
|
A:JGF501
|
3.7
|
10.4
|
0.5
|
CBK
|
A:JGF501
|
3.7
|
17.2
|
0.5
|
CBM
|
A:JGF501
|
3.8
|
16.3
|
0.5
|
CAK
|
A:JGF501
|
3.9
|
13.7
|
0.5
|
CAJ
|
A:JGF501
|
4.0
|
9.5
|
0.5
|
CAH
|
A:JGF501
|
4.0
|
12.0
|
0.5
|
CAJ
|
A:JGF501
|
4.0
|
11.4
|
0.5
|
CAK
|
A:JGF501
|
4.0
|
12.8
|
0.5
|
CAH
|
A:JGF501
|
4.0
|
11.0
|
0.5
|
CBJ
|
A:JGF501
|
4.1
|
10.6
|
0.5
|
CAR
|
A:JGF501
|
4.1
|
10.2
|
0.5
|
CAR
|
A:JGF501
|
4.1
|
12.1
|
0.5
|
CAA
|
A:JGF501
|
4.2
|
11.0
|
0.5
|
CAA
|
A:JGF501
|
4.2
|
9.7
|
0.5
|
NAM
|
A:JGF501
|
4.2
|
14.9
|
0.5
|
NAM
|
A:JGF501
|
4.2
|
15.6
|
0.5
|
CBL
|
A:JGF501
|
4.2
|
16.5
|
0.5
|
O
|
A:HOH682
|
4.3
|
33.0
|
1.0
|
CAF
|
A:JGF501
|
4.6
|
11.1
|
0.5
|
CAF
|
A:JGF501
|
4.6
|
9.6
|
0.5
|
FBN
|
A:JGF501
|
4.6
|
11.8
|
0.5
|
CG
|
A:LEU381
|
4.7
|
18.0
|
1.0
|
CAP
|
A:JGF501
|
4.7
|
9.9
|
0.5
|
CE1
|
A:HIS433
|
4.7
|
17.2
|
1.0
|
CAP
|
A:JGF501
|
4.8
|
11.6
|
0.5
|
CAQ
|
A:JGF501
|
4.8
|
10.4
|
0.5
|
FBO
|
A:JGF501
|
4.8
|
10.5
|
0.5
|
CAQ
|
A:JGF501
|
4.9
|
12.1
|
0.5
|
CD1
|
A:LEU381
|
4.9
|
19.6
|
1.0
|
FBN
|
A:JGF501
|
4.9
|
17.0
|
0.5
|
|
Fluorine binding site 2 out
of 4 in 7wmu
Go back to
Fluorine Binding Sites List in 7wmu
Fluorine binding site 2 out
of 4 in the Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:10.5
occ:0.50
|
FBO
|
A:JGF501
|
0.0
|
10.5
|
0.5
|
CBM
|
A:JGF501
|
1.2
|
16.3
|
0.5
|
CBI
|
A:JGF501
|
1.3
|
10.4
|
0.5
|
CBL
|
A:JGF501
|
2.1
|
16.5
|
0.5
|
CBJ
|
A:JGF501
|
2.3
|
10.6
|
0.5
|
CAV
|
A:JGF501
|
2.3
|
9.8
|
0.5
|
CAV
|
A:JGF501
|
2.4
|
15.5
|
0.5
|
OAU
|
A:JGF501
|
2.7
|
9.5
|
0.5
|
OAU
|
A:JGF501
|
2.9
|
13.7
|
0.5
|
SD
|
A:MET438
|
3.2
|
25.3
|
1.0
|
CBK
|
A:JGF501
|
3.3
|
17.2
|
0.5
|
CG
|
A:PRO371
|
3.4
|
10.1
|
1.0
|
CBK
|
A:JGF501
|
3.6
|
10.9
|
0.5
|
CBI
|
A:JGF501
|
3.6
|
17.2
|
0.5
|
CBM
|
A:JGF501
|
3.6
|
10.4
|
0.5
|
CAT
|
A:JGF501
|
3.7
|
9.7
|
0.5
|
CG2
|
A:VAL435
|
3.8
|
11.9
|
1.0
|
CB
|
A:VAL435
|
3.8
|
12.3
|
1.0
|
CAT
|
A:JGF501
|
3.8
|
12.2
|
0.5
|
CE
|
A:MET438
|
3.9
|
18.9
|
1.0
|
CBJ
|
A:JGF501
|
3.9
|
16.9
|
0.5
|
CZ2
|
A:TRP370
|
4.0
|
14.0
|
1.0
|
CA
|
A:VAL435
|
4.0
|
11.6
|
1.0
|
CB
|
A:PRO371
|
4.1
|
10.2
|
1.0
|
CBL
|
A:JGF501
|
4.1
|
10.5
|
0.5
|
CAS
|
A:JGF501
|
4.1
|
9.9
|
0.5
|
CAS
|
A:JGF501
|
4.2
|
12.0
|
0.5
|
CH2
|
A:TRP370
|
4.2
|
13.8
|
1.0
|
N
|
A:VAL435
|
4.3
|
13.2
|
1.0
|
FBN
|
A:JGF501
|
4.5
|
17.0
|
0.5
|
O
|
A:HOH653
|
4.7
|
20.6
|
1.0
|
CE2
|
A:TRP370
|
4.7
|
13.4
|
1.0
|
FBN
|
A:JGF501
|
4.7
|
11.8
|
0.5
|
CAJ
|
A:JGF501
|
4.8
|
9.5
|
0.5
|
CD
|
A:PRO371
|
4.8
|
10.1
|
1.0
|
C
|
A:ASP434
|
4.8
|
13.6
|
1.0
|
FBO
|
A:JGF501
|
4.8
|
20.3
|
0.5
|
CAJ
|
A:JGF501
|
4.8
|
11.4
|
0.5
|
CG
|
A:MET438
|
4.9
|
17.5
|
1.0
|
CB
|
A:ASP434
|
5.0
|
16.8
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 7wmu
Go back to
Fluorine Binding Sites List in 7wmu
Fluorine binding site 3 out
of 4 in the Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:17.0
occ:0.50
|
FBN
|
A:JGF501
|
0.0
|
17.0
|
0.5
|
FBN
|
A:JGF501
|
0.6
|
11.8
|
0.5
|
CBK
|
A:JGF501
|
1.4
|
17.2
|
0.5
|
CBK
|
A:JGF501
|
1.5
|
10.9
|
0.5
|
CBJ
|
A:JGF501
|
2.2
|
10.6
|
0.5
|
CBL
|
A:JGF501
|
2.4
|
16.5
|
0.5
|
CBJ
|
A:JGF501
|
2.5
|
16.9
|
0.5
|
CBL
|
A:JGF501
|
2.7
|
10.5
|
0.5
|
O
|
A:HOH653
|
3.2
|
20.6
|
1.0
|
O
|
A:HOH699
|
3.4
|
39.5
|
1.0
|
CBI
|
A:JGF501
|
3.5
|
10.4
|
0.5
|
OD2
|
A:ASP434
|
3.6
|
20.1
|
1.0
|
CBM
|
A:JGF501
|
3.7
|
16.3
|
0.5
|
CBI
|
A:JGF501
|
3.7
|
17.2
|
0.5
|
CBM
|
A:JGF501
|
3.9
|
10.4
|
0.5
|
CB
|
A:ASP434
|
4.0
|
16.8
|
1.0
|
CAV
|
A:JGF501
|
4.2
|
9.8
|
0.5
|
CAV
|
A:JGF501
|
4.2
|
15.5
|
0.5
|
CG
|
A:ASP434
|
4.3
|
19.3
|
1.0
|
CE1
|
A:HIS433
|
4.3
|
17.2
|
1.0
|
O
|
A:HOH683
|
4.4
|
22.0
|
1.0
|
FBO
|
A:JGF501
|
4.5
|
10.5
|
0.5
|
NE2
|
A:HIS433
|
4.8
|
17.5
|
1.0
|
FBO
|
A:JGF501
|
4.9
|
20.3
|
0.5
|
O
|
A:HOH682
|
5.0
|
33.0
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 7wmu
Go back to
Fluorine Binding Sites List in 7wmu
Fluorine binding site 4 out
of 4 in the Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of the Second Bromodomain of Human BRD2 in Complex with the Inhibitor Y13146 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F501
b:11.8
occ:0.50
|
FBN
|
A:JGF501
|
0.0
|
11.8
|
0.5
|
FBN
|
A:JGF501
|
0.6
|
17.0
|
0.5
|
CBK
|
A:JGF501
|
1.4
|
10.9
|
0.5
|
CBK
|
A:JGF501
|
1.5
|
17.2
|
0.5
|
CBJ
|
A:JGF501
|
2.2
|
16.9
|
0.5
|
CBL
|
A:JGF501
|
2.4
|
10.5
|
0.5
|
CBJ
|
A:JGF501
|
2.4
|
10.6
|
0.5
|
CBL
|
A:JGF501
|
2.7
|
16.5
|
0.5
|
O
|
A:HOH699
|
3.3
|
39.5
|
1.0
|
CBI
|
A:JGF501
|
3.6
|
17.2
|
0.5
|
O
|
A:HOH653
|
3.7
|
20.6
|
1.0
|
CBI
|
A:JGF501
|
3.7
|
10.4
|
0.5
|
CBM
|
A:JGF501
|
3.7
|
10.4
|
0.5
|
CBM
|
A:JGF501
|
3.9
|
16.3
|
0.5
|
OD2
|
A:ASP434
|
4.1
|
20.1
|
1.0
|
CAV
|
A:JGF501
|
4.2
|
9.8
|
0.5
|
CAV
|
A:JGF501
|
4.2
|
15.5
|
0.5
|
CE1
|
A:HIS433
|
4.3
|
17.2
|
1.0
|
CB
|
A:ASP434
|
4.5
|
16.8
|
1.0
|
O
|
A:HOH682
|
4.5
|
33.0
|
1.0
|
O
|
A:HOH683
|
4.6
|
22.0
|
1.0
|
FBO
|
A:JGF501
|
4.6
|
20.3
|
0.5
|
NE2
|
A:HIS433
|
4.7
|
17.5
|
1.0
|
CG
|
A:ASP434
|
4.7
|
19.3
|
1.0
|
FBO
|
A:JGF501
|
4.7
|
10.5
|
0.5
|
|
Reference:
J.Li,
C.Zhang,
H.Xu,
C.Wang,
R.Dong,
H.Shen,
X.Zhuang,
X.Chen,
Q.Li,
J.Lu,
M.Zhang,
X.Wu,
K.M.Loomes,
Y.Zhou,
Y.Zhang,
J.Liu,
Y.Xu.
Structure-Based Discovery and Optimization of Furo[3,2- C ]Pyridin-4(5 H )-One Derivatives As Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (Bet) Inhibitors. J.Med.Chem. V. 65 5760 2022.
ISSN: ISSN 0022-2623
PubMed: 35333526
DOI: 10.1021/ACS.JMEDCHEM.2C00100
Page generated: Fri Aug 2 14:54:01 2024
|